Viral-encoded cyclins

Current Opinion in Genetics and Development

Volumn 10, Issue 1, 2000, Pages 70-74

  Laman, Heike ^a   Mann, David J ^b   Jones, Nic C ^c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; VIRUS PROTEIN;

CELL CYCLE; ENZYME SPECIFICITY; ENZYME STRUCTURE; HERPES VIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; VIRUS CARCINOGENESIS;

EID: 0033994275     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(99)00045-3     Document Type: Review

References (51)

1. Sherr C.J. D-type cyclins. Trends Biochem Sci. 20:1995;187-190.
2. Sherr C.J. G1 phase progression: cycling on cue. Cell. 79:1994;551-555.
3. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512.
4. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
5. Reed S.I. Control of the G1/S transition. Cancer Surv. 29:1997;7-23.
6. Perez-Roger I., Kim S.H., Griffiths B., Sewing A., Land H. Cyclins D1 and D2 mediate Myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J. 18:1999;5310-5320.
7. Polyak K., Kato J.Y., Solomon M.J., Sherr C.J., Massague J., Roberts J.M., Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9-22.
8. McConnell B.B., Gregory F.J., Stott F.J., Hara E., Peters G. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2- associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol Cell Biol. 19:1999;1981-1989.
9. Bouchard C., Thieke K., Maier A., Saffrich R., Hanley-Hyde J., Ansorge W., Reed S., Sicinski P., Bartek J., Eilers M. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18:1999;5321-5333.
10. Albrecht J.C., Nicholas J., Biller D., Cameron K.R., Biesinger B., Newman C., Wittmann S., Craxton M.A., Coleman H., Fleckenstein B. Primary structure of the herpesvirus saimiri genome. J Virol. 66:1992;5047-5058.
11. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., Moore P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA. 93:1996;14862-14867.
12. Virgin H.W., Latreille P., Wamsley P., Hallsworth K., Weck K.E., Dal Canto A.J., Speck S.H. Complete sequence and genomic analysis of murine γ herpesvirus 68. J Virol. 71:1997;5894-5904.
13. Godden-Kent D., Talbot S.J., Boshoff C., Chang Y., Moore P., Weiss R.A., Mittnacht S. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol. 71:1997;4193-4198.
14. Chang Y., Moore P.S., Talbot S.J., Boshoff C.H., Zarkowska T., Godden K., Paterson H., Weiss R.A., Mittnacht S. Cyclin encoded by KS herpesvirus. Nature. 382:1996;410.
15. Jung J.U., Stager M., Desrosiers R.C. Virus-encoded cyclin. Mol Cell Biol. 14:1994;7235-7244.
16. Li M., Lee H., Yoon D.W., Albrecht J.C., Fleckenstein B., Neipel F., Jung J.U. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol. 71:1997;1984-1991.
17. Swanton C., Mann D.J., Fleckenstein B., Neipel F., Peters G., Jones N. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature. 390:1997;184-187.
18. Matsushime H., Quelle D.E., Shurtleff S.A., Shibuya M., Sherr C.J., Kato J.Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol. 14:1994;2066-2076.
19. Kip1.
20. Kip1-mediated block to cell-cycle progression.
21. Sheaff R.J., Groudine M., Gordon M., Roberts J.M., Clurman B.E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1997;1464-1478.
22. Vlach J., Hennecke S., Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16:1997;5334-5344.
23. Tsvetkov L.M., Yeh K.H., Lee S.J., Sun H., Zhang H. p27(Kip1) ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated thr187 in p27. Curr Biol. 9:1999;661-664.
24. Muller D., Bouchard C., Rudolph B., Steiner P., Stuckmann I., Saffrich R., Ansorge W., Huttner W., Eilers M. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene. 15:1997;2561-2576.
25. Duro D., Schulze A., Vogt B., Bartek J., Mittnacht S., Jansen D.P. Activation of cyclin A gene expression by the cyclin encoded by human herpesvirus-8. J Gen Virol. 80:1999;549-555.
26. DeCaprio J.A., Ludlow J.W., Figge J., Shew J.Y., Huang C.M., Lee W.H., Marsilio E., Paucha E., Livingston D.M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell. 54:1988;275-283.
27. Dyson N., Howley P.M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:1989;934-937.
28. Chen S., Paucha E. Identification of a region of simian virus 40 large T antigen required for cell transformation. J Virol. 64:1990;3350-3357.
29. Figge J., Webster T., Smith T.F., Paucha E. Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A, and myc oncoproteins. J Virol. 62:1988;1814-1818.
30. Dowdy S.F., Hinds P.W., Louie K., Reed S.I., Arnold A., Weinberg R.A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell. 73:1993;499-511.
31. Ewen M.E., Sluss H.K., Sherr C.J., Matsushime H., Kato J., Livingston D.M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 73:1993;487-497.
32. Kelly B.L., Wolfe K.G., Roberts J.M. Identification of a substrate targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein. Proc Natl Acad Sci USA. 95:1998;2535-2540. The authors identify a VXCXE motif in cyclin E that is important for binding and phosphorylating pRb, as well as binding of its CDK catalytic partner.
33. Adams P.D., Li X., Sellers W.R., Baker K.B., Leng X., Harper J.W., Taya Y., Kaelin W.G. Jr. Retinoblastoma, protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes. Mol Cell Biol. 19:1999;1068-1080.
34. Schulman B.A., Lindstrom D.L., Harlow E. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci USA. 95:1998;10453-10458. These authors describe experiments that identify a substrate docking site on cyclin A. A hydrophobic patch, characterized by the MRAIL sequence, was mutated at several residues and then tested for its ability to interact with substrate proteins containing RXL motifs. These data suggest that the hydrophobic patch is involved in substrate recruitment of cdk2. The addition of a second substrate docking site, an LXCXE motif, onto the amino-terminus of cyclin A with substitutions in its hydrophobic patch restored substrate targeting.
35. Morgan D.O. The dynamics of cyclin dependent kinase structure. Curr Opin Cell Biol. 8:1996;767-772.
36. Pavletich N.P. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol. 287:1999;821-828.
37. Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massagué J., Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 376:1995;313-320.
38. Schulze-Gahmen U., Jung J.U., Kim S.H. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6. Structure Fold Des. 7:1999;245-254. This paper presents the first crystal structure of a viral cyclin. The solved structure shows that V cyclin has an overall structure that is similar to that of cyclin A and cyclin H. The authors model a V cyclin/cdk2 model based on the solved structure of cyclin A/cdk2. They propose that the lack of binding to CKIs is due to a change in the shape of the substrate binding pocket as well as substitutions of critical contact residues within the cyclin.
39. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., Moore P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA. 93:1996;14862-14867.
40. Peeper D.S., Parker L.L., Ewen M.E., Toebes M., Hall F.L., Xu M., Zantema A., van der Eb A.J., Piwnica-Worms H. A- and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes. EMBO J. 12:1993;1947-1954.
41. Horton L.E., Templeton D.J. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity. Oncogene. 14:1997;491-498.
42. Roberts J.M. Evolving ideas about cyclins. Cell. 98:1999;129-132.
43. Flore O., Rafii S., Ely S., O'Leary J.J., Hyjek E.M., Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature. 394:1998;588-592. The authors describe the ability of KSHV to infect and transform primary human enodothelial cells. Infected endothelial cells have a spindle-shaped morphology and continue to survive for months after infection, as a result in part of a continued responsiveness to VEGF. At sub-physiological concentrations of VEGF, infected cells underwent lytic replication producing progeny virions. Remarkably, only 5% of the cells in culture contained KSHV DNA, and the uninfected cells survive via a paracrine effect. Uninfected cells treated with conditioned media from KSHV-infected cells assume a spindle-shaped morphology and upregulate the VEGF receptor. KSHV-infected cells had telomerase activity and were capable of anchorage-independent growth.
44. Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E.G., Gutkind J.S., Asch A.S., Cesarman E., Gershengorn M.C., Mesri E.A. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 391:1998;86-89. This report describes experiments that test the contribution of G-protein-coupled receptor kinase to KSHV-mediated oncogenesis. The KSHV-GPCR causes focus formation in NIH3T3 cells, which can be inhibited by certain GPCR-specific kinases. Focus-derived cells, when injected into nude mice, can develop into tumors. Conditioned medium supporting the growth of GPCR-transfected cells was positive in a microtubule-formation assay as well as a co-culture matrigel assay. This conditioned media contained higher levels of VEGF, which appears to mediate an angiogenic response.
45. Muralidhar S., Pumfery A.M., Hassani M., Sadaie M.R., Kishishita M., Brady J.N., Doniger J., Medveczky P., Rosenthal L.J. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol. 72:1998;4980-4988.
46. van Dyk L., Hess J.L., Katz J.D., Jacoby M., Speck S.H., Virgin H.W. The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes. J Virol. 73:1999;5110-5122. This report details the construction of a transgenic mouse that expresses γ-HV68 viral cyclin during early T-cell development. The effect of cyclin expression on thymus and T cell development, as well as its effects on proliferation and apoptosis, are described. Notably, the expression of viral cyclin correlates with the development of high-grade lymphoblastic lymphoma in 40% of transgenic mice.
47. Lovec H., Grzeschiczek A., Kowalski M.B., Moroy T. Cyclin D1/bcl-1 ooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 13:1994;3487-3495.
48. Bodrug S.E., Warner B.J., Bath M.L., Lindeman G.J., Harris A.W., Adams J.M. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 13:1994;2124-2130.
49. LaPierre L.A., Casey J.W., Holzschu D.L. Walleye retroviruses associated with skin tumors and hyperplasias encode cyclin D homologs. J Virol. 72:1998;8765-8771.
50. Albrecht J.C. Primary structure of the Herpesvirus ateles genome. J Virol. 74:2000;1033-1037.
51. Ojala P.M., Tiainen M., Salven P., Veikkola T., Castaños-Vélez E., Sarid R., Biberfels P., Mäkelä T.P. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. Cancer Res. 59:1999;4984-4989.